Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies?
by: Darryl Leong
Should cardiovascular disease comorbidity scare you during the COVID-19 season?
by: Jeemon Panniyammakal
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
by: Lucrecia M. Burgos
The link between smoking and COVID 19; should we wait for more evidence to quit smoking?
by: Jeemon Panniyammakal
Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19)
by: Lucrecia M. Burgos
Cardiac Biomarkers and COVID19
by: Darryl Leong
The Implications of Viral Particles in the Myocardium
by: Darryl Leong
Impact of the COVID-19 pandemic on interventional cardiology activity
by: Lucrecia M. Burgos
Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension
by: Lucrecia M. Burgos
Multimorbidity and COVID 19: A catastrophic combination
by: Jeemon Panniyammakal
COVID-19 and critical care admissions in the UK: using routine data during a pandemic.
by: Alice M. Jackson
EMPTY HOSPITALS: ARE WE CREATING A TICKING TIME BOMB FOR CARDIOVASCULAR DISEASE PATIENTS
by: Lilian Mbau
Do hypertension patients have high risk for COVID-19?
by: Eduardo Chuquiure-Valenzuela
Ethnicity, cardio-vascular disease and COVID-19 in the UK
by: Alice M. Jackson
The indirect consequences of COVID-19
by: Alice M. Jackson
Virtual health and COVID-19: Is this the future of cardiovascular disease care delivery?
by: Lilian Mbau
Heart failure and COVID-19: A dynamic and changing interaction
by: Eduardo Chuquiure-Valenzuela
Cardiac rehabilitation in the time of COVID19
by: Abraham Samuel Babu
Do COVID STEMIs have a higher thrombus burden? More questions & implications
by: Aaysha Cader
The long cardiovascular tail of the pandemic
by: Amitava Banerjee
The Heart in the Time of COVID-19 